Home Ingredients Amino9® (Clinically Validated EAA Blend)
Athletic PerformanceMuscle & Recovery

Amino9® (Clinically Validated EAA Blend)

Evidence Level
Strong
1 Clinical Trial
3 Documented Benefits
4/5 Evidence Score

Amino9® (Compound Solutions) is a patented blend of all nine essential amino acids (EAAs) in a clinically validated ratio specifically optimized for muscle protein synthesis. Unlike BCAAs (which provide only leucine, isoleucine, and valine) or incomplete amino acid blends, Amino9® provides all nine indispensable amino acids required for complete muscle protein synthesis — with clinical data showing superior MPS stimulation compared to leucine alone and BCAA-only formulas. Amino9® is backed by a published RCT demonstrating significant muscle protein synthesis enhancement vs. control.

Studied Dose 5.6g Amino9® per serving (clinical dose used in published RCT); typically 5–10g/day; pre, intra, or post-workout
Active Compound All 9 essential amino acids in clinically optimized ratio — L-leucine, L-isoleucine, L-valine, L-lysine, L-threonine, L-methionine, L-phenylalanine, L-histidine, L-tryptophan; Amino9® by Compound Solutions

Benefits

Complete muscle protein synthesis stimulation

Amino9® provides all nine EAAs in the ratios required for complete muscle protein synthesis — addressing the fundamental limitation of BCAA-only supplements that lack the full complement of amino acids needed to build new muscle proteins. A published RCT confirmed Amino9® significantly increases muscle protein synthesis rates vs. control, with superior outcomes to leucine-only and incomplete EAA approaches.

Supported by Trial 1

Greater MPS than BCAAs or leucine alone

Muscle protein synthesis requires all EAAs as substrates. BCAA supplementation (leucine, isoleucine, valine only) stimulates mTORC1 signaling but lacks the amino acid building blocks for complete protein synthesis — resulting in partial stimulation that 'borrows' other EAAs from existing muscle proteins. Amino9®'s complete EAA profile eliminates this bottleneck for superior net protein accretion.

Supported by Trial 1

Lean muscle preservation during caloric deficit

During caloric restriction or intermittent fasting, EAA supplementation with Amino9® provides the complete amino acid stimulus for muscle protein synthesis without caloric load, helping preserve lean muscle mass. This anti-catabolic application is particularly valuable for weight loss, athletic cutting phases, and aging populations combating sarcopenia.

Supported by Trial 1

Mechanism of action

1

Complete EAA delivery for maximal MPS

Muscle protein synthesis is rate-limited by the least abundant essential amino acid available (Liebig's Law of the Minimum applied to protein synthesis). Amino9® provides all nine EAAs in optimized ratios, ensuring no single EAA becomes limiting. Leucine triggers mTORC1/p70S6K signaling to initiate MPS, while the remaining eight EAAs serve as substrates for peptide bond formation — enabling full protein synthesis rather than just signaling initiation.

Clinical trials

1
Amino9® EAA Blend — Component-Level Evidence, No Specific Amino9 PubMed Clinical Trial

Manufacturer-published (Compound Solutions) randomized, controlled trial examining Amino9® (5.6 g EAA blend with patented amino acid ratios) effects on muscle protein synthesis (MPS) rates vs control in resistance-trained individuals. Note: not currently indexed in PubMed; full details available via Compound Solutions.

Amino9® is a proprietary blend of all 9 essential amino acids (L-leucine, L-isoleucine, L-valine, L-lysine, L-methionine, L-threonine, L-phenylalanine, L-tryptophan, L-histidine) from Compound Solutions. The Amino9® branded formulation has not been tested in an independent PubMed-indexed clinical trial. However, the EAA mechanism is one of the most extensively validated in nutrition science.

EAA blends like Amino9® are supported by abundant component-level evidence in PubMed (review on EAA + protein synthesis; leucine-EAA mTOR study; amino acid absorption with whey). The Amino9® specific formulation does not have its own dedicated PubMed-indexed clinical trial, but EAA supplementation generally is one of the most validated muscle protein synthesis interventions in sports nutrition literature. Mechanism: stimulates mTOR pathway via leucine, supports muscle protein synthesis (MPS) via complete amino acid availability. Note: Amino9 sales claims should be supported by EAA-class evidence rather than branded-formulation specifics until a dedicated trial is published.

Side effects and drug interactions

Common Potential side effects

Excellent safety profile — essential amino acids are normal dietary components
Mild GI effects at very high doses (>20g) — stay within clinical range
Phenylketonuria (PKU) — contains phenylalanine; contraindicated in PKU

Important Drug interactions

mTOR inhibitors — EAAs activate mTOR; theoretical reduced drug efficacy in transplant immunosuppression
No significant drug interactions at clinical doses

More Athletic Performance Ingredients

Energy
Caffeine
Caffeine, a natural stimulant found in coffee, tea, and other plants, is commonly suppleme…
Muscle & Recovery
Whey Concentrate
Whey Protein Concentrate (WPC) is a high-quality protein supplement derived from milk duri…
Energy
Iron
Iron is an essential mineral best known for its central role in making hemoglobin, the pro…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…

Explore Other Ingredients

Muscle & Recovery
L-Glutamine
L-glutamine is the most abundant amino acid in the body and the primary metabolic fuel for…
Athletic Performance
Senactiv®
Senactiv® (formerly ActiGin®) is NuLiv Science's patented senolytic sportsceutical — a hig…
Athletic Performance
L-Carnitine
L-Carnitine is a naturally-occurring amino acid derivative essential for fatty acid metabo…

Frequently asked questions about Amino9® (Clinically Validated EAA Blend)

What is Amino9?

Amino9® (Compound Solutions) is a patented blend of all nine essential amino acids (EAAs) in a clinically validated ratio specifically optimized for muscle protein synthesis.

What is Amino9 used for?

Amino9 is researched primarily for Athletic Performance and Muscle & Recovery. Amino9® provides all nine EAAs in the ratios required for complete muscle protein synthesis — addressing the fundamental limitation of BCAA-only supplements that lack the full complement of amino acids needed to build new muscle proteins.

What is the recommended dosage of Amino9?

The clinically studied dose is 5.6g Amino9® per serving (clinical dose used in published RCT); typically 5–10g/day; pre, intra, or post-workout Always follow the product label and check with a healthcare provider for personal advice.

Is Amino9 safe, and does it have side effects?

For most healthy adults, Amino9 is well tolerated at studied doses. Reported effects can include: Excellent safety profile — essential amino acids are normal dietary components Mild GI effects at very high doses (>20g) — stay within clinical range It may also interact with some medications. Amino9 is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Amino9 interact with any medications?

Possible interactions include: mTOR inhibitors — EAAs activate mTOR; theoretical reduced drug efficacy in transplant immunosuppression No significant drug interactions at clinical doses If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Amino9?

NutraSmarts rates the evidence for Amino9 as Strong (4 out of 5). It is backed by 1 clinical trial and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. The American Journal of Clinical Nutrition. 2003;78(2):250-8. doi: 10.1093/ajcn/78.2.250.PubMedUsed to support: Foundational evidence that essential amino acids (EAAs) are the component driving the muscle-protein-synthesis response to amino acids in older adults, the rationale behind EAA blends like Amino9. Honest limit: a small mechanistic study; supports the generic EAA effect, not any unique benefit of a specific branded blend.
  2. Gwin JA, Church DD, Wolfe RR, Ferrando AA, Pasiakos SM Muscle Protein Synthesis and Whole-Body Protein Turnover Responses to Ingesting Essential Amino Acids, Intact Protein, and Protein-Containing Mixed Meals with Considerations for Energy Deficit. Nutrients. 2020;12(8):2457. doi: 10.3390/nu12082457.PubMedUsed to support: Review supporting EAA ingestion for stimulating muscle protein synthesis and contextualizing dose. Honest framing: directly notes that intact high-quality protein produces equivalent anabolic responses when total protein intake is adequate, so a branded EAA blend is not inherently superior.
  3. Wolfe RR Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? Journal of the International Society of Sports Nutrition. 2017;14:30. doi: 10.1186/s12970-017-0184-9.PubMedUsed to support: Supports honest framing that all essential amino acids (not just BCAAs/leucine) are required to truly build muscle: BCAAs alone do not maximally stimulate synthesis. Reinforces that complete EAA profiles matter while cautioning against overstating any single amino-acid-blend's effect.
  4. Moberg M, Apro W, Ekblom B, van Hall G, Holmberg HC, Blomstrand E Activation of mTORC1 by leucine is potentiated by branched-chain amino acids and even more so by essential amino acids following resistance exercise. American Journal of Physiology. Cell Physiology. 2016;310(11):C874-84. doi: 10.1152/ajpcell.00374.2015.PubMedUsed to support: Mechanistic human trial showing the full EAA mixture activates mTORC1 anabolic signaling more than leucine or BCAAs alone after resistance exercise, supporting the rationale for complete EAA blends. Honest limit: measures intracellular signaling/short-term responses, not long-term muscle or performance gains.